Chitosan–Hydrazone-Modified Calcium Phosphate Scaffolds: Fabrication, Characterization, and Drug Delivery Potential
Authors:
- Teodora JakovljevićTJTeodora Jakovljević
- Jelena StanisavljevićJSJelena Stanisavljević
- Julijana StevanovićJSJulijana Stevanović
- Miloš PetkovićMPMiloš Petković
- Ivana Z. MatićIMIvana Z. Matić
- Miloš PapićMiloš Papić
- Suzana ŽivanovićSŽSuzana Živanović
- Tamara MatićTMTamara Matić
- Vukašin UgrinovićVUVukašin Ugrinović
- Djordje JanaćkovićDJDjordje Janaćković
- Biljana LjujićBLBiljana Ljujić
- Djordje VeljovićDVDjordje Veljović
Open Access
- 15 September 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (9) , 2270
Abstract
Background/Objectives: Recent advancements in biomaterials aimed at closely mimicking natural biological tissues hold great promise for hard tissue regeneration and controlled drug release due to their superior physical, chemical, and biological properties. This study aimed to develop multi-ion doped calcium hydroxyapatite (HAp) scaffolds with chitosan-based coatings for localized drug delivery, incorporating a novel hydrazone compound with potential anticancer activity. Methods: HAp powders doped with magnesium (Mg2+), strontium (Sr2+), and varying fluoride (F−) contents (0–2 mol.%) were synthesized via a hydrothermal method. Scaffolds were fabricated using the sponge replica technique and subsequently coated with chitosan or a chitosan–hydrazone blend. Dopant incorporation was confirmed by electron dispersive X-ray spectroscopy (EDS). Phase composition and morphology were analyzed via X-ray diffraction (XRD) and scanning electron microscopy (SEM). Mechanical properties, bioactivity, cytotoxicity, and hydrazone release profiles were systematically evaluated. Results: EDS confirmed successful incorporation of Mg2+ and Sr2+ in all powders, while F− was detected only in powders with 1 and 2 mol.% fluoride. XRD and SEM revealed the phase composition and scaffold microstructure. Chitosan coatings significantly improved scaffold compressive strength and reduced degradation rate, indicating enhanced stability in biological environments. The coated scaffolds supported MRC-5 fibroblast viability. The hydrazone compound exhibited dose-dependent antitumor cytotoxicity comparable to cisplatin and showed sustained release from scaffolds for up to 15 days. Conclusions: The combination of multi-ion doped HAp scaffolds and chitosan–hydrazone coatings provides a promising platform for bone tissue engineering and localized cancer therapy, demonstrating both mechanical stability and controlled, sustained drug release.Keywords
Funding Information
- Science Fund of Republic of Serbia (7470, 451-03-136/2025-03/200135, 451-03-136/2025-03/200287, 451-03-136/2025-03/200043)
- Ministry of Science, Technological Development and Innovations, Republic of Serbia (7470, 451-03-136/2025-03/200135, 451-03-136/2025-03/200287, 451-03-136/2025-03/200043)
This publication has 75 references indexed in Scilit:
- Nanoscale hydroxyapatite/chitosan polymer coatings: Synthesis and characterizationPolymer Composites, 2023
- Soft 3D hybrid network for delivery and controlled release of poorly soluble dihydropyrimidinone compound: An insight into the novel system for potential application in leukemia treatmentJournal of Biomedical Materials Research Part A, 2022
- Bone regeneration with hydroxyapatite-based biomaterialsEmergent Materials, 2019
- The effect of hydroxyapatite in biopolymer-based scaffolds on release of naproxen sodiumJournal of Biomedical Materials Research Part A, 2016
- Substituted hydroxyapatites for bone regeneration: A review of current trendsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2016
- Magnesium biomaterials for orthopedic application: A review from a biological perspectiveJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2014
- Microwave sintering improves the mechanical properties of biphasic calcium phosphates from hydroxyapatite microspheres produced from hydrothermal processingJournal of Materials Science, 2010
- Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6)Journal of Immunological Methods, 1991
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963